Cellular structures show link with survival outcomes in ccRCC
Among those with Signature II tumors, overall survival was improved among those who received nivolumab compared with those who received everolimus.
Related Articles
Health Span-Lifespan Gaps Widening Globally
Sex difference identified, with women exhibiting a wider health span-lifespan gap than men
BCG-Unresponsive NMIBC: Insights for Newer Treatment Modalities
Katie S. Murray, DO, offers advice to urologists considering the adoption of newer treatment modalities for BCG-unresponsive non–muscle-invasive bladder cancer (NMIBC), encouraging them to integrate…
Time Burdens Associated With Cancer Care
Time burdens associated with cancer care extend beyond the burden of time spent accessing care outside the home.
Editorial Comment | Journal of Urology
Can’t sign in? Forgot your password? If the addres s matches an existing account you will receive an email with instructions to reset your password.…
Amy Pearlman, MD, and Gia Ching on starting a private urology practice
“I think that it’s so important right now to really, really stand as your own brand and really, really have a cultivated patient population that…
EAU Guidelines on Testicular Cancer – DISEASE MANAGEMENT – Uroweb
The aim of these guidelines is to present the current evidence for the diagnosis and treatment of patients with cancer of the testis.
Overcoming Challenges in Prostate Cancer Care Access With Transportation Services | Urology Practice
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Editor’s Choice | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Chad Ritenour, MD, on balancing patient expectations and physician well-being
“This idea that physicians and medical teams always feel that they need to be available at all hours of the day really starts to stress…